Acumen Pharmaceuticals IncThought some might be interested.....a few weeks back, I had posted something in regards with Acumen Pharma (a close competitor to Promis working on the same toxic oligomers targets) was going public in the near future .....well they did on July 1.
So the company market cap is sitting at 675M as of today with 37M shares outstanding. Not much information is disclosed on their site when compared to PROMIS, but they have initiated a Phase 1 clinical study of their lead drug (and only one from what I can see) .
So yeah, 10X more than PROMIS, but based on what? Who knows....but I hope that's where were heading in a years time!
Good luck (and patience) to all!
https://seekingalpha.com/article/4437332-acumen-pharmaceuticals-pursues-125-million-ipo